References
- WiersingaWMBartalenaLEpidemiology and prevention of Graves’ ophthalmopathyThyroid20021285586012487767
- TjiangHLahootiHMcCorquodaleTParmarKRWallJREye and eyelid abnormalities are common in patients with Hashimoto’s thyroiditisThyroid20102028729020146657
- WallJThyroid function: news and views: pathogenesis of Graves’ ophthalmopathy – a role for TSH-R?Nat Rev Endocrinol20143725625824663219
- GirgisCMChampionBLWallJRGirgisCChampionBWallJCurrent concepts of Graves’ disease: a reviewTher Adv Endocrinol Metab2012213514423148179
- WeetmanAPGraves’ diseaseN Engl J Med20003431236124811071676
- EcksteinAKPlichtMLaxHThyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the diseaseJ Clin Endocrinol Metab2006913464347016835285
- PaschkeRVassartGLudgateMCurrent evidence for and against the TSH receptor being the common antigen in Graves’ disease and thyroid associated ophthalmopathyClin Endocrinol (Oxf)1995425655697634495
- McCorquodaleTLahootiHGopinathBWallJRLong term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity – heterogeneity of autoimmune ophthalmopathyClin Ophthalmol201261922259229
- LahootiHHoutzJATranYCTSH receptor antibodies as measured in a thyroid stimulating immunoglobulin (TSI) reporter bioassay are not detected in patients with euthyroid Graves’ diseaseAustin J Clin Ophthalmol2014117
- GirgisCMChampionBLWallJRPsychological stress and soft-tissue manifestations of Graves’ disease: a potential link?AACE Clin Case Rep2015
- BartleyGBFatourechiVKadrmasEFClinical features of Graves’ ophthalmopathy in an incidence cohortAm J Ophthalmol19961212842908597271
- KonishiJHermanMNKrissJPBinding of thyroglobulin and thyroglobulin-anti thyroglobulin complex to extraocular muscle membraneEndocrinology1974954344464136562
- McDougallIRKrissJPNew thoughts about the cause and treatment of the severe ocular manifestations of Graves’ diseaseScot Med J1974191651694601348
- Feldt-RasmussenUKempABechKMadsenANDateJSerum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmosActa Endocrinol (Coph)198196192198
- KurokiTRufTWhelanLMillerAWallJRAntithyroglobulin monoclonal and autoantibodies cross-reactivity on orbital connective tissue antigen. A possible mechanism for the association of ophthalmopathy with autoimmune thyroid disordersClin Exp Immunol198569931936
- KodamaKSikorskaHBaylyRBandy-DafoePWallJUse of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathyJ Clin Endocrinol Metab19745967736327760
- GohSYHoSCSeahLLFongKSKhooDHThyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multi antigenic diseaseClin Endocrinol (Oxf)20046060060715104563
- MarinoMLisiSPincheraAIdentification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathyThyroid20011117718511288989
- MarinòMChiovatoLLisiSRole of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisitedJ Endocrinol Invest20042723023615164998
- Kendall-TaylorPAtkinsonSHolcombeMSpecific IgG in Graves’ ophthalmopathy and its relation to retro-orbital and thyroid autoimmunityBMJ1984288118311866424781
- LahootiHShanmuganathanTChampionBWallJRSerum thyroglobulin levels in patients with thyroid autoimmunity with and without ophthalmopathy or isolated upper eyelid retractionInt Trends Immun201532227
- SmithTJTSH-receptor-expressing fibrocytes and thyroid associated ophthalmopathyNat Rev Endocrinol20151117118125560705
- SmithTJHegedüsLDouglasRSRole of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathyBest Pract Res Clin Endocrinol Metab20122629130222632366
- FernandoRLuYAtkinsSJMesterTBranhamKSmithTJExpression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter and thyroperoxidase by fibrocytes depends on AIREClin Endocrinol Metab201499E1236E244
- FernandoRAtkinsSRaychaudhuriNHuman fibrocytes co-express thyroglobulin and thyrotropin receptorProc Natl Acad Sci U S A20121097427743222517745
- SmithTJTsaC-CShihM-JUnique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathyThyroid20081898398818788919
- RotellaCMZonefratiRToccafondiRValenteWAKohnLDAbility of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves’ seraJ Clin Endocrinol Metab1986623573672416769
- HansenCFraitureBRouhiROttoEFörsterGKahalyGHPLC glycosaminoglycan analysis in patients with Graves’ diseaseClin Sci (Lond)1997925115179176026
- KahalyGStoverCOttoEBeyerJSchulerMGlycosaminoglycans in thyroid-associated ophthalmopathyAutoimmunity19921381881420810
- MadedduGCasuARCostanzaCSerum thyroglobulin levels in the diagnosis and follow-up of subacute ‘painful’ thyroiditis. A sequential studyArch Intern Med19851452432473977482
- Feldt-RasmussenUBechKDateJThyroid stimulating antibodies, thyroglobulin antibodies and serum proteins during treatment of Graves’ disease with radioiodine or propylthiouracilAllergy1982371611676127965
- EinhornJFagraeusAJonssonJThyroid antibodies after 131I treatment for hyperthyroidismJ Clin Endo Metab19652512181224
- BartelenaLMarocciCBogazziFPanicucciMLepriAPincheraAUse of corticosteroids to prevent progression of Graves’ ophthalmopathy after radioiodine therapy for hyperthyroidismN Engl J Med1989321134913522811943
- MarcocciCBartalenaLBogazziFBruno-BossioGPincheraARelationship between Graves’ ophthalmopathy and type of treatment of Graves’ hyperthyroidismThyroid199221711781525588
- BoyleITGreigWRThomsonJAWinningJMcGirrEMEffect of thyroid ablation on dysthyroid exophthalmosProc R Soc Med196962119235818232
- CatzBPerzikSLTotal thyroidectomy in the management of thyrotoxic and euthyroid Graves’ diseaseAm J Surg19691184344394185884
- KuriharaHTotal Thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathyThyroid20021226526711952051
- AntonelliAFerrariSMCorradoAExtra-ocularmuscle cells from patients with Graves’ ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγAutoimmun Rev2014131160116625172242
- AntonelliARotondiMFerrariSMInterferon-γ-inducible α-chemokine CXCL10 involvement in Graves’ ophthgalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonistsJ Clin Endocrinol Metab20069161462016303841
- MysliwiecJPalygaIKosciuszkoMKowalskaAGorskaMCirculating CXCL9 and CXCL10 as markers of activity of Graves’ orbitopathy during treatment with corticosteroids and teleradiotherapyHorm Metab Res2012441395796122752955
- LahootiHCultroneDEdirimanneSAssociation of the CASQ1 gene rs3838216 with Graves’ ophthalmopathy and Hashimoto’s thyroiditis in patients with thyroid autoimmunityOphthalmol Res20142281229
- MizokamiTLiAWWallJRStress and thyroid autoimmunityThyroid2004141047105515650357